164 related articles for article (PubMed ID: 29438162)
1. Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.
Kabat GC; Kim MY; Lane DS; Zaslavsky O; Ho GYF; Luo J; Nicholson WK; Chlebowski RT; Barrington WE; Vitolins MZ; Lin X; Liu S; Rohan TE
Eur J Cancer Prev; 2018 May; 27(3):261-268. PubMed ID: 29438162
[TBL] [Abstract][Full Text] [Related]
2. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.
Kabat GC; Kim M; Caan BJ; Chlebowski RT; Gunter MJ; Ho GY; Rodriguez BL; Shikany JM; Strickler HD; Vitolins MZ; Rohan TE
Int J Cancer; 2009 Dec; 125(11):2704-10. PubMed ID: 19588485
[TBL] [Abstract][Full Text] [Related]
3. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
[TBL] [Abstract][Full Text] [Related]
4. Fasting glucose is a risk factor for breast cancer: a prospective study.
Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
Pan K; Chlebowski RT; Mortimer JE; Gunter MJ; Rohan T; Vitolins MZ; Adams-Campbell LL; Ho GYF; Cheng TD; Nelson RA
Cancer; 2020 Aug; 126(16):3638-3647. PubMed ID: 32530506
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.
Desai P; Wallace R; Anderson ML; Howard BV; Ray RM; Wu C; Safford M; Martin LW; Rohan T; Manson JE; Simon MS
Gynecol Oncol; 2018 Mar; 148(3):540-546. PubMed ID: 29422345
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
[TBL] [Abstract][Full Text] [Related]
8. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease.
Catsburg C; Gunter MJ; Chen C; Cote ML; Kabat GC; Nassir R; Tinker L; Wactawski-Wende J; Page DL; Rohan TE
Cancer Res; 2014 Jun; 74(12):3248-58. PubMed ID: 24755474
[TBL] [Abstract][Full Text] [Related]
9. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
[TBL] [Abstract][Full Text] [Related]
10. Serum lipids and risk of obesity-related cancers in postmenopausal women.
Kabat GC; Kim MY; Chlebowski RT; Vitolins MZ; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2018 Jan; 29(1):13-24. PubMed ID: 29197994
[TBL] [Abstract][Full Text] [Related]
11. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
Anderson GL; Judd HL; Kaunitz AM; Barad DH; Beresford SA; Pettinger M; Liu J; McNeeley SG; Lopez AM;
JAMA; 2003 Oct; 290(13):1739-48. PubMed ID: 14519708
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk in metabolically healthy but overweight postmenopausal women.
Gunter MJ; Xie X; Xue X; Kabat GC; Rohan TE; Wassertheil-Smoller S; Ho GY; Wylie-Rosett J; Greco T; Yu H; Beasley J; Strickler HD
Cancer Res; 2015 Jan; 75(2):270-4. PubMed ID: 25593034
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
Wang T; Rohan TE; Gunter MJ; Xue X; Wactawski-Wende J; Rajpathak SN; Cushman M; Strickler HD; Kaplan RC; Wassertheil-Smoller S; Scherer PE; Ho GY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):971-7. PubMed ID: 21415362
[TBL] [Abstract][Full Text] [Related]
14. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
[TBL] [Abstract][Full Text] [Related]
15. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative.
Cespedes Feliciano EM; Hohensee C; Rosko AE; Anderson GL; Paskett ED; Zaslavsky O; Wallace RB; Caan BJ
JAMA Netw Open; 2020 Sep; 3(9):e2016747. PubMed ID: 32926116
[TBL] [Abstract][Full Text] [Related]
16. Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative.
Adams SV; Quraishi SM; Shafer MM; Passarelli MN; Freney EP; Chlebowski RT; Luo J; Meliker JR; Mu L; Neuhouser ML; Newcomb PA
Environ Health Perspect; 2014 Jun; 122(6):594-600. PubMed ID: 24633137
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer.
Lambe M; Wigertz A; Garmo H; Walldius G; Jungner I; Hammar N
Cancer Causes Control; 2011 Aug; 22(8):1163-71. PubMed ID: 21688131
[TBL] [Abstract][Full Text] [Related]
18. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
[TBL] [Abstract][Full Text] [Related]
19. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.
Eliassen AH; Hankinson SE
Adv Exp Med Biol; 2008; 630():148-65. PubMed ID: 18637490
[TBL] [Abstract][Full Text] [Related]
20. A healthy lifestyle index and its association with risk of breast, endometrial, and ovarian cancer among Canadian women.
Arthur R; Kirsh VA; Kreiger N; Rohan T
Cancer Causes Control; 2018 Jun; 29(6):485-493. PubMed ID: 29667103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
